I am an objective investor. I am not, however, an investor who invests in rumors. I like evidence, especially SEC filings.
I don't see ANY evidence that William Gartner is doing anything with DR-70 or Radient other than trying to get funding for an LLC called Global Cancer Diagnostics that, if funded, would attempt to sell DR-70 on the internet.
There is no evidence that William Gartner has been a driving force in biotech for many years. There is some conjecture, and perhaps some wishful thinking, that Gartner is successfully doing something, but the evidence I see is the following:
* Radient filed an 8-K in 2012 saying GCDX didn't get funding and the agreement was cancelled.
* GCDx does not reply to emails and their voice mailbox has been full for well over a year.
* GCDx entered a contest on Fundable in 2013 but dropped out after raising only $200.
* Gartner promised to start selling DR-70 on his website in June 2012 but it never happened.
* GCDx applied for a TRADEMARK, but owns no patent.
So to be clear, I am not DOWNPLAYING Gartner's "Role as driving force between bringing together the Takeover Group, Provista, RXPC, Amarantus, GCDx, and Dignyte." I am saying there is nothing TO downplay.
The takeover rumor is over three years old now. It was created in March 2011. This rumor no longer has legs, IMO. Without some hard evidence, like a Schedule 13 or a press release or an SEC filing, I think it's folly to keep believing a rumor like this. That does NOT mean I am not objective.
